Clinical Trial Update: A Study Of Valsartan Used To Treat Hypertension For Up To 56 Weeks In Children Ages 1 - 5 Years Who Have Hypertension [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating valsartan for treating hypertension in children aged 1 to 5 years has completed (up to 56 weeks of treatment).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• VALSARTAN (Valsartan)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 3 | Status: COMPLETED